CXCL12 and Alzheimer disease: Additionally, significant differences in CXCL12 were observed between AD patients and controls (p <  0.001) as well as between AD patients and MCI subjects (p =  0.005), but not between MCI subjects and the control group, whereas, for Ng, differences were only observed between AD and controls (p <  0.001) (Table 2).